Monday · October 12, 2026

 ·  Daily  ·  Newsletters

Resonance network: Quantum InsiderSpace Insider

AI Insider, powered by Resonance
Subscribe
Topic

Antibody-Drug Conjugate Development

Technology & Infrastructure · Applications & agents

Lantern Pharma Advances AI-Driven Antibody-Drug Conjugate Development

Lantern Pharma Inc. (NASDAQ: LTRN), a leader in AI-driven oncology drug discovery, has announced significant advancements in applying its RADR® AI platform to the development of antibody-drug conjugates (ADCs). As the global ADC market

4 Feb 2025 · 2 min read

Trending today

Business & Markets · Startups

FireDome Launches US Operations With California Wildfire Defense Test Site
Business & Markets

Stuut Secures $52.5M Series B Led by Insight Partners to Scale AI Agents for Order-to-Cash
a square object with a knot on it
Business & Markets

OpenAI Faces Scrutiny Over Math Proof Standards and Revenue Figures Reportedly $20B Below Earlier Estimates
Physical AI · Humanoids

Deep Robotics Tests DR02 Humanoids in Hangzhou Traffic and Tourist Areas
Business & Markets

Valon Raises $150M Series D at a $2.3B Valuation to Deploy ValonOS and AI Agents into Mortgage
The AI economy, every weekday morning

The daily briefing on LinkedIn. Free, one tap to follow.

Subscribe on LinkedIn

The AI economy, every weekday morning

The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.

Subscribe on LinkedIn